s-(1,2-dichlorovinyl)cysteine has been researched along with Diabetic Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dnyanmote, AV; Latendresse, JR; Lock, EA; Mehendale, HM; Sawant, SP; Warbritton, AA | 1 |
1 other study(ies) available for s-(1,2-dichlorovinyl)cysteine and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair.
Topics: Animals; Area Under Curve; Blood Urea Nitrogen; Bromodeoxyuridine; Cell Nucleus; Colchicine; Creatinine; Cysteine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Half-Life; Immunohistochemistry; Injections, Intraperitoneal; Kidney Tubules, Proximal; Lyases; Male; Mice; Proliferating Cell Nuclear Antigen; Regeneration; S Phase; Streptozocin; Thymidine; Tritium | 2006 |